LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 70 filers reported holding LARIMAR THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $26,368 | -43.7% | 3,637 | -41.1% | 0.00% | -100.0% |
| Q1 2024 | $46,853 | +325.5% | 6,173 | +155.1% | 0.00% | – |
| Q4 2023 | $11,011 | -40.5% | 2,420 | -48.4% | 0.00% | -100.0% |
| Q3 2023 | $18,514 | -52.6% | 4,687 | -62.4% | 0.00% | 0.0% |
| Q2 2023 | $39,019 | +650216.7% | 12,466 | +809.3% | 0.00% | – |
| Q1 2023 | $6 | -100.0% | 1,371 | -88.4% | 0.00% | -100.0% |
| Q3 2022 | $38,000 | +1800.0% | 11,822 | +836.8% | 0.00% | – |
| Q2 2022 | $2,000 | -60.0% | 1,262 | +3.9% | 0.00% | – |
| Q1 2022 | $5,000 | -58.3% | 1,215 | +7.9% | 0.00% | – |
| Q4 2021 | $12,000 | -82.1% | 1,126 | -80.7% | 0.00% | -100.0% |
| Q3 2021 | $67,000 | +415.4% | 5,843 | +334.4% | 0.00% | – |
| Q2 2021 | $13,000 | +30.0% | 1,345 | +89.4% | 0.00% | – |
| Q1 2021 | $10,000 | -75.6% | 710 | -63.3% | 0.00% | -100.0% |
| Q4 2020 | $41,000 | -30.5% | 1,935 | -50.2% | 0.00% | 0.0% |
| Q3 2020 | $59,000 | +195.0% | 3,883 | +148.1% | 0.00% | 0.0% |
| Q2 2020 | $20,000 | – | 1,565 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Owl Capital Holdings LP | 3,859,468 | $27,981,143 | 7.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 21,231,974 | $153,931,812 | 2.56% |
| Altium Capital Management LP | 693,000 | $5,024,250 | 2.05% |
| STEMPOINT CAPITAL LP | 704,349 | $5,106,530 | 1.50% |
| DAFNA Capital Management LLC | 639,974 | $4,639,812 | 1.11% |
| RA Capital Management | 6,045,351 | $43,828,795 | 0.58% |
| Altium Capital Management LP | 196,000 | $1,421,000 | 0.58% |
| MANGROVE PARTNERS IM, LLC | 855,815 | $6,204,659 | 0.48% |
| Ikarian Capital, LLC | 323,528 | $2,345,578 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 312,469 | $2,265,400 | 0.31% |